Skip to main content
. 2013 Nov;16(11):1403–1409. doi: 10.1089/jpm.2013.0245

Table 6.

Responses to Questions on Guidelines for Assessing and Managing Cancer Pain

Question (Response)
What level of need do you think there is for the following? (Some need/urgent need) (n=77)%
An Australian guideline for nonpharmacologic management of cancer pain 92%
An Australian guideline for pharmacologic management of cancer pain 90%
Implementation strategy to inform use of existing guidelines in and across different service settings 90%
An Australian guideline for assessing cancer pain 90%
In a new Australian implementation strategy for guidelines on cancer pain, how useful would the following be? (Somewhat/very useful) (n=77)%
Advice on best practice for specific cases of cancer pain (e.g., nociceptive) 96%
Inclusion of patient 'action plans' to aid self-management 95%
Guidance on assessing patient-identified priorities 92%
Guidance on roles for each discipline 90%
Templates for taking case histories and identifying patient-identified priorities 84%
Patient version of implementation strategy 79%
Inclusion of key performance indicators 74%
One or more guideline routinely used in primary workplace? (n=87)%
 Yes 45%
Which specific guideline(s) used routinely in primary workplace (n=32)%
 (Australian) Palliative Care Expert Group (2010): Therapeutic Guidelines— Palliative Care. Version 3 66%
 Institutional or departmental guideline(s) 31%
 NHMRC (2006): Guidelines for a palliative approach in residential aged care 16%
 European Association for Palliative Care (2001): Morphine and alternative opioids in cancer pain; the EAPC recommendations 13%
 American Pain Society (2005): Guidelines for the management of cancer pain in adults and children 9%
 European Society for Medical Oncology (2007): Minimum clinical recommendations for the management of cancer pain 3%
 National Comprehensive Cancer Network (2010): Clinical practice guidelines in Oncology - adult cancer pain 3%
 National Institutes of Health (2002): Symptom management in cancer: pain, depression and fatigue 3%
 Palliative Care in Paediatric Oncology 3%
 APSOC Guidelines for the management of neuropathic pain (APSOC—Management in pain in residential aged care facilities) 3%
 Therapeutic guidelines 9%
 Palliative Care Formulary 3rd Edition Twycross & Wilcock 3%
 Twycross Therapeutics in Terminal Cancer 3%
 Cancer Institute EVIQ 3%
 Internal guidelines and policies are used regarding analgesia and analgesics 3%
 Burst Ketamine Guidelines Methadone Guidelines (Perth) 3%
 Paediatric Palliative Care references 3%
 Own silver chain guidelines, developed from looking at other published info 3%
 Peter Mac Cancer Pain Management Guidelines 3%
 Peter MacCallum Guidelines Western Health Victoria Guidelines 3%
 Victorian Eastern Metropolitan Regional Palliative Care Consortia Opioid Conversion Guidelines 3%
 We have developed our own guidelines for the management of uncontrolled cancer pain 3%
 NHMRC Acute Pain Guidelines 3%
 Analgesics Therapeutic Guidelines—Palliative Care 3%
Perceptions about guideline use (Agree/strongly agree)—completed by (n=32)%
One or more guideline working well 100%
Use of pain guideline(s) at my primary workplace influence(s) patient outcomes 78%
There are adequate resources at my primary workplace to provide care according to one or more pain guideline(s) 78%
My service endorses use of one or more particular pain guideline(s) 78%
Clinical staff at my primary workplace adhere to the same pain guideline(s) 72%